RIPK1 and myeloid sarcoma: Phosphorylation of receptor-interacting protein kinase 1 (RIPK1) in astrocytes and microglia triggers a detrimental neuroinflammatory program that contributes to the neurodegenerative environment in MS (Figure 4) [75].